Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
7 April 2015 |
Main ID: |
NCT00004827 |
Date of registration:
|
24/02/2000 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Study of Docosahexaenoic Acid (DHA) Supplementation in Patients With X-Linked Retinitis Pigmentosa
|
Scientific title:
|
|
Date of first enrolment:
|
March 1996 |
Target sample size:
|
46 |
Recruitment status: |
Completed |
URL:
|
http://clinicaltrials.gov/show/NCT00004827 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
|
Phase:
|
N/A
|
|
Contacts
|
Name:
|
Dennis R. Hoffman |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Retina Foundation of the Southwest |
| | |
Key inclusion & exclusion criteria
|
PROTOCOL ENTRY CRITERIA:
--Disease Characteristics--
Diagnosis of X-linked retinitis pigmentosa
Early stage disease Sufficient cone function determined by recordable ERG (30 Hz
amplitude; greater than 0.32 microvolts) Visual fields greater than 20 degrees Sufficient
rod function (greater than 3.0 microvolts amplitude)
Media clarity sufficient for fundus photography
--Prior/Concurrent Therapy--
No concurrent use of anticoagulant medication
--Patient Characteristics--
- No chronic metabolic disease that may interfere with fatty acid metabolism
- No bleeding of clinical significance
Age minimum:
N/A
Age maximum:
N/A
Gender:
Male
|
Health Condition(s) or Problem(s) studied
|
Retinitis Pigmentosa
|
Intervention(s)
|
Drug: docosahexaenoic acid
|
Secondary ID(s)
|
RFS-FDR001232
|
199/13351
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|